Article Information
History
- February 29, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Lucy R Williams, MSc1,#,
- Katherine R W Emary, DPhil2,3,
- Daniel J Phillips, MMath2,3,
- Jodie Hay, PhD4,
- Jessica P J Larwood, BMBCh2,3,
- Maheshi N Ramasamy, DPhil2,3,5,
- Andrew J Pollard, FMedSci2,3,
- Nicholas C Grassly, DPhil1,* and
- Merryn Voysey, DPhil2,3,*,#
- 1MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, United Kingdom
- 2Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom
- 3NIHR Oxford Biomedical Research Centre, Oxford United Kingdom
- 4Paul O’Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, United Kingdom
- 5Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
- ↵#Corresponding author:
Lucy R. Williams, Department of Infectious Disease Epidemiology, Imperial College London, Sir Michael Uren Hub, London, W12 0BZ, United Kingdom, (lucy.williams19{at}imperial.ac.uk), Alternative corresponding author:
Merryn Voysey, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, CCVTM, Churchill Rd, Headington, Oxford, OX3 7LE, United Kingdom (merryn.voysey{at}paediatrics.ox.ac.uk)
Posted February 29, 2024.
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
